These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 18797268)

  • 41. Mood changes correlate to changes in brain serotonin precursor trapping in women with premenstrual dysphoria.
    Eriksson O; Wall A; Marteinsdottir I; Agren H; Hartvig P; Blomqvist G; Långström B; Naessén T
    Psychiatry Res; 2006 Mar; 146(2):107-16. PubMed ID: 16515859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Premenstrual dysphoric disorder: evidence for a new category for DSM-5.
    Epperson CN; Steiner M; Hartlage SA; Eriksson E; Schmidt PJ; Jones I; Yonkers KA
    Am J Psychiatry; 2012 May; 169(5):465-75. PubMed ID: 22764360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Premenstrual Dysphoric Disorder (PMDD)].
    Yamada K
    Seishin Shinkeigaku Zasshi; 2015; 117(4):292-8. PubMed ID: 26524841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening of patients for clinical trials of premenstrual syndrome/premenstrual dysphoric disorder: methodological issues.
    Halbreich JT; Halbreich U; Smail N
    Psychiatry Res; 2006 Mar; 141(3):349-52. PubMed ID: 16499978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Premenstrual syndrome and premenstrual dysphoric disorder-Overview on pathophysiology, diagnostics and treatment].
    Haußmann J; Goeckenjan M; Haußmann R; Wimberger P
    Nervenarzt; 2024 Mar; 95(3):268-274. PubMed ID: 38393358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Premenstrual syndrome: current knowledge and management.
    Robinson GE
    CMAJ; 1989 Mar; 140(6):605-11. PubMed ID: 2645986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Premenstrual syndrome: review of literature].
    Lastrico A; Andreoli A; Campana A
    Minerva Psichiatr; 1994 Dec; 35(4):243-53. PubMed ID: 7861947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Late luteal phase dysphoric disorder (premenstrual syndromes): clinical implications.
    Blumenthal SJ; Nadelson CC
    J Clin Psychiatry; 1988 Dec; 49(12):469-73. PubMed ID: 3058678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Premenstrual dysphoric disorder: diagnosis and therapeutic strategy].
    Bianchi-Demicheli F
    Rev Med Suisse; 2006 Feb; 2(52):393-4, 397-9. PubMed ID: 16523546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of premenstrual syndrome and its relationship with blood pressure in young adult females.
    Okeahialam BN; Obindo JT; Ogbonna C
    Afr J Med Med Sci; 2008 Dec; 37(4):361-7. PubMed ID: 19301714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Premenstrual Dysphoric Disorder: Epidemiology and Treatment.
    Hantsoo L; Epperson CN
    Curr Psychiatry Rep; 2015 Nov; 17(11):87. PubMed ID: 26377947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder.
    Thys-Jacobs S; McMahon D; Bilezikian JP
    Am J Obstet Gynecol; 2008 May; 198(5):506.e1-8. PubMed ID: 18199422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comorbid bipolar disorder and premenstrual dysphoric disorder: real patients, unanswered questions.
    Frey BN; Minuzzi L
    Arch Womens Ment Health; 2013 Feb; 16(1):79-81. PubMed ID: 23135309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Premenstrual affective syndrome and psychiatric disorder.
    Kashiwagi T; McClure JN; Wetzel RD
    Dis Nerv Syst; 1976 Mar; 37(3):116-9. PubMed ID: 943281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevalence of premenstrual syndrome in reproductive women and its influential factors].
    Zhao G; Wang L; Qu C
    Zhonghua Fu Chan Ke Za Zhi; 1998 Apr; 33(4):222-4. PubMed ID: 10682469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comorbidity as a predictor and moderator of treatment outcome in youth with anxiety, affective, attention deficit/hyperactivity disorder, and oppositional/conduct disorders.
    Ollendick TH; Jarrett MA; Grills-Taquechel AE; Hovey LD; Wolff JC
    Clin Psychol Rev; 2008 Dec; 28(8):1447-71. PubMed ID: 18973971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The premenstrual syndrome: effectiveness of Vitex agnus castus].
    Döll M
    Med Monatsschr Pharm; 2009 May; 32(5):186-91. PubMed ID: 19469189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormonal management of premenstrual syndrome.
    Usman SB; Indusekhar R; O'Brien S
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Does menstrual cycle affect mood disorders?].
    Akdeniz F; Karadağ F
    Turk Psikiyatri Derg; 2006; 17(4):296-304. PubMed ID: 17183446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.